Alaunos Therapeutics | ZIOP - Assets



Alaunos Therapeutics reported $2.76M in Assets for its fiscal quarter ending in December of 2024.


Assets Change Date
Adcock Ingram Holdings ZAR 8.74B 388.13M Dec/2024
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Amgen USD 87.9B 1.47B Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
Baxter International USD 21.3B 4.48B Mar/2025
Biogen USD 28.33B 297.1M Jun/2025
Bioline Rx USD 43.27M 240K Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Celltrion KRW 20.96T 96.41B Mar/2025
Corcept Therapeutics USD 801.72M 44.73M Jun/2025
Cspc Pharmaceutical CNY 44.39B 3.51B Dec/2024
Dianthus Therapeutics USD 326.08M 47.93M Jun/2025
Divis Laboratories Ltd 169.32B 13.46B Mar/2025
Gilead Sciences USD 55.72B 713M Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Incyte USD 5.82B 71.99M Jun/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Kangmei Pharma CNY 13.64B 69.1M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 869.6M 37.58M Jun/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 65.33M 6.17M Dec/2024
Merck USD 117.52B 2.4B Jun/2025
Neuren Pharmaceuticals AUD 409.71M 181.55M Dec/2024
Novartis USD 104.4B 4.45B Jun/2025
Organigram Holdings CAD 564.62M 85.41M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Pharma Mar EUR 348.25M 14.75M Jun/2025
PTC Therapeutics USD 2.63B 21.23M Jun/2025
Qiagen NV USD 5.82B 278.39M Jun/2025
Regeneron Pharmaceuticals USD 38.22B 674M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sartorius EUR 10.03B 85.1M Jun/2025
Sino Biopharmaceutical CNY 65.41B 1.3B Dec/2024
TG Therapeutics USD 702.61M 45.92M Jun/2025
Tilray USD 4.19B 70.11M Nov/2024
Zz Pientze Pharmaceu 18.71B 224.21M Jun/2025